BR9708145A - Processo para tratamento de dor de enxaqueca - Google Patents

Processo para tratamento de dor de enxaqueca

Info

Publication number
BR9708145A
BR9708145A BR9708145A BR9708145A BR9708145A BR 9708145 A BR9708145 A BR 9708145A BR 9708145 A BR9708145 A BR 9708145A BR 9708145 A BR9708145 A BR 9708145A BR 9708145 A BR9708145 A BR 9708145A
Authority
BR
Brazil
Prior art keywords
treating migraine
migraine pain
pain
treating
migraine
Prior art date
Application number
BR9708145A
Other languages
English (en)
Inventor
Harlan E Shannon
Daniel E Womer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9708145A publication Critical patent/BR9708145A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BR9708145A 1996-03-25 1997-03-24 Processo para tratamento de dor de enxaqueca BR9708145A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1412796P 1996-03-25 1996-03-25
PCT/US1997/004471 WO1997035582A1 (en) 1996-03-25 1997-03-24 Method for treating migraine pain

Publications (1)

Publication Number Publication Date
BR9708145A true BR9708145A (pt) 1999-07-27

Family

ID=21763694

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9708145A BR9708145A (pt) 1996-03-25 1997-03-24 Processo para tratamento de dor de enxaqueca

Country Status (17)

Country Link
US (1) US5929070A (pt)
EP (1) EP0932407A4 (pt)
JP (1) JP2001508759A (pt)
KR (1) KR20000004966A (pt)
CN (1) CN1106196C (pt)
AU (1) AU721290B2 (pt)
BR (1) BR9708145A (pt)
CA (1) CA2250186A1 (pt)
CZ (1) CZ298398A3 (pt)
EA (1) EA000769B1 (pt)
IL (1) IL126063A (pt)
NO (1) NO984432L (pt)
NZ (1) NZ332037A (pt)
PL (1) PL329221A1 (pt)
UA (1) UA44838C2 (pt)
WO (1) WO1997035582A1 (pt)
YU (1) YU42098A (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997035583A1 (en) * 1996-03-25 1997-10-02 Eli Lilly And Company Method for treating pain
UA48219C2 (uk) * 1996-03-25 2002-08-15 Елі Ліллі Енд Компані Композиція для вгамування болю (варіанти) та спосіб вгамування болю
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
CN1717237A (zh) 2002-11-26 2006-01-04 艾利斯达分子传输公司 洛沙平和阿莫沙平在制备治疗疼痛的药物中的应用
CN1726037B (zh) * 2002-11-26 2010-05-05 艾利斯达医药品公司 抗精神病药用于制备通过吸入传送治疗头痛的药物中的应用
ATE510174T1 (de) 2003-05-21 2011-06-15 Alexza Pharmaceuticals Inc Schlag gezündete unabhängige heizeinheit
US7829700B2 (en) 2004-09-06 2010-11-09 Shasun Chemicals And Drugs Limited Process for preparation of a pharmaceutically pure polymorphic form I of Olanzapine
ES2594867T3 (es) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Unidad de calentamiento para usar en un dispositivo de administración de fármaco
US11400048B2 (en) 2014-06-25 2022-08-02 Synergia Bio Sciences Private Limited Pharmaceutical oil-in-water nano-emulsion
JP6634034B2 (ja) 2014-06-25 2020-01-22 シネルジア・バイオ・サイエンシーズ・プライベイト・リミテッドＳｙｎｅｒｇｉａ Ｂｉｏ Ｓｃｉｅｎｃｅｓ Ｐｒｉｖａｔｅ Ｌｉｍｉｔｅｄ 医薬水中油型ナノエマルジョン

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
KR940701258A (ko) * 1991-06-21 1994-05-28 피터 죤 기딩즈 문맥압 항진증 및 편두통의 치료를 위한 테트라하이드로벤즈아제핀 유도체의 용도
DK206591D0 (da) * 1991-12-23 1991-12-23 Lundbeck & Co As H Behandling af psykoser
DE69329887T2 (de) * 1992-05-29 2001-05-23 Lilly Co Eli Thienobenzodiazepinderivate zur Behandlung von Störungen des Zentralnervensystems
HUT75522A (en) * 1994-03-11 1997-05-28 Lilly Co Eli Indole-, pyrido-indole-, indolo-quinoline- and benzo-pyrido-indole-derivatives, method for treating 5ht2b receptor related conditions, pharmaceutical compositions containing them
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine

Also Published As

Publication number Publication date
KR20000004966A (ko) 2000-01-25
EP0932407A4 (en) 2002-04-24
JP2001508759A (ja) 2001-07-03
CN1219876A (zh) 1999-06-16
PL329221A1 (en) 1999-03-15
EP0932407A1 (en) 1999-08-04
WO1997035582A1 (en) 1997-10-02
NZ332037A (en) 2001-01-26
AU2584597A (en) 1997-10-17
NO984432D0 (no) 1998-09-23
US5929070A (en) 1999-07-27
CN1106196C (zh) 2003-04-23
CA2250186A1 (en) 1997-10-02
AU721290B2 (en) 2000-06-29
EA199800864A1 (ru) 1999-02-25
CZ298398A3 (cs) 1999-06-16
EA000769B1 (ru) 2000-04-24
NO984432L (no) 1998-11-24
IL126063A0 (en) 1999-05-09
IL126063A (en) 2002-04-21
YU42098A (sh) 1999-09-27
UA44838C2 (uk) 2002-03-15

Similar Documents

Publication Publication Date Title
BR9708254A (pt) Método para o tratamento da dor
BR9510077A (pt) Aparelho e processo para tratamento e distribuição de águas servidas
BR9704292A (pt) Processo de e aparelho para expansão de tabaco
BR9701152A (pt) Processo e aparelho para eliminação de interferência
BR9706874A (pt) Processo para tratar uma formação subterrânea
BR9400571A (pt) Processo para o tratamento de despejo orgânico
BR9604872A (pt) Composição para tratamento de cabelo
BR9709610A (pt) Processo para distribuir artigos absorventes
BR9711530A (pt) Combina-Æo de terapia para tratamento de psicoses
BR9708908A (pt) Processo para tratamento de inflamação
BR9704496A (pt) Processo de tratamento de água residual
BR9510088A (pt) Processo para desinfecção de água processo para desinfecção e tratamento de água artigos para desinfecção de água e remoção de substâncias prejudiciais da água
BR9701330A (pt) Processo e aparelho para refinamento de silício
PT954642E (pt) Processo e dispositivo para limpar sulcos de carril
BR9506271A (pt) Processo para o tratamento de aves domésticas
BR9710099A (pt) Processo para produzir compostos
PT940381E (pt) Processo para recuperacao de ciclopentano e/ou ciclopenteno
PT917879E (pt) Processo melhorado para estabilizacao de proteinas
BR9704986A (pt) Processo de síntese de uréia aperfeiçoado e aparelho para o mesmo
BR9708246A (pt) Metodo para tratamento de dor
BR9708145A (pt) Processo para tratamento de dor de enxaqueca
BR9601294A (pt) Composto e processo para preparação do mesmo
BR9502950A (pt) Agentes de curtimento processo para sua preparação de método de curtimento
BR9804951A (pt) Processo e aparelho para produ-Æo de composto
BR9701454A (pt) Processo para limpar agulhas cirúrgicas

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
B09B Patent application refused [chapter 9.2 patent gazette]